Access to Kidney Transplant of Obese Patients Beginning Dialysis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04748770

Acronym

Transplantob

Enrollment

100

Registered

2021-02-10

Start date

2021-01-11

Completion date

2026-06-01

Last updated

2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comorbidities, Dialysis, Kidney Transplant Access, Obese Patients

Keywords

Kidney transplant access, obese patients, dialysis, comorbidities

Brief summary

Obesity is in constant increase all over the world and affects 35% of the global population according to the World Health Organisation. It is associated with other cardiovascular risk factors (particularly hypertension and diabetes) and with high morbi-mortality. It is also responsible for an increase of the risk of developing chronic kidney diseases (CKD). In fact, obese patients represent 25% of the dialysis population and Picardy is one of the most affected areas. However, their access to kidney transplant is still restricted and the reasons are not completely understood.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Age over 18 years old. * Patients with BMI≥30 kg/m2 (for study population) and 25≤BMI≤30 kg/m2(for control population) one month after dialysis initiation. * Patients agree with their data collection.

Exclusion criteria

* Patients with bariatric surgery history. * Patients needed dialysis for graft dysfunction. * Data loss.

Design outcomes

Primary

Measure	Time frame
variation of pre-transplant status two years after the obese patients' dialysis initiation between both groups	two years

Countries

France

Contacts

CONTACTPauline Caillard, MD

caillard.pauline@chu-amiens.fr03 22 45 58 66

Outcome results